Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Biogenyx is a private regenerative medicine and aesthetics company operating as a next-generation clinic rather than a drug-development biotech. The company markets science-backed regenerative treatments focused on hair restoration, wellness, vitality, and cellular renewal, with an emphasis on non-invasive and clinic-based services. Its public-facing materials position the business around regenerative care, longevity, and aesthetic optimization rather than a conventional therapeutic pipeline. Based on available information, Biogenyx appears to be a commercial healthcare services business with no disclosed clinical-stage drug assets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Biogenyx.